NCT04711642 - Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

January 15, 2022

Study Completion Date

July 15, 2023

Conditions

Dry Eye DiseaseDry Eye SyndromeEvaporative Dry EyeCataractPhacoemulsification

Interventions

DRUG

The study will include three arms, one non interventional and 2 interventions. The intervention arms will include two commercially available sodium hyaluronate 0.1% (Systane ultra plus and Hylo-comod)

All groups will receive a topical steroid-antibiotic for 3 weeks. The study groups will be also prescribed eye drops containing sodium hyaluronate 0.1% from the postoperative day 7 for 4 weeks.